Consensus paper of the WFSBP task force on biological markers: Biological markers for alcoholism

World Journal of Biological Psychiatry

Volumn 14, Issue 8, 2013, Pages 549-564

  Hashimoto, Eri ^a   Riederer, Peter Franz ^b   Hesselbrock, Victor M ^c   Hesselbrock, Michie N ^c   Mann, Karl ^d   Ukai, Wataru ^a   Sohma, Hitoshi ^e   Thibaut, Florence ^f   Schuckit, Marc A ^g   Saito, Toshikazu ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e SAPPORO MEDICAL UNIVERSITY   (Japan)

^f ROUEN UNIVERSITY HOSPITAL   (France)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Abuse; Alcohol; Alcohol dependence; Alcohol use disorder; Biochemical markers

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; 5 HYDROXYTRYPTOPHOL; ACAMPROSATE; ACETALDEHYDE; ADENYLATE CYCLASE; ALANINE AMINOTRANSFERASE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ASPARTATE AMINOTRANSFERASE; BETA ENDORPHIN; BETA N ACETYLHEXOSAMINIDASE; BIOLOGICAL MARKER; CARBOHYDRATE DEFICIENT TRANSFERRIN; CREATINE KINASE; DOPAMINE; ETHYL GLUCURONIDE; FATTY ACID ESTER; GAMMA GLUTAMYLTRANSFERASE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALMEFENE; NALTREXONE; OLANZAPINE; OPIATE RECEPTOR; SALSOLINOL; SEROTONIN; SERTRALINE; SIALIC ACID;

ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ALCOHOL USE DISORDER; ALCOHOLISM; AMYGDALOID NUCLEUS; ARTICLE; BRAIN SIZE; CHEMICAL ANALYSIS; CLINICAL FEATURE; CLINICAL PRACTICE; CONSENSUS; COPY NUMBER VARIATION; CRIMINAL JUSTICE; DISEASE COURSE; DRUG BIOAVAILABILITY; DRUG HALF LIFE; ELECTROPHYSIOLOGY; ENVIRONMENTAL FACTOR; GENETIC POLYMORPHISM; GENETIC TRAIT; GEOGRAPHY; GRAY MATTER; HOSPITAL CARE; HUMAN; MEAN CORPUSCULAR VOLUME; NEUROIMAGING; PRIMARY MEDICAL CARE; PROTEIN EXPRESSION; SUBCORTEX; TREATMENT RESPONSE; WHITE MATTER; WORKPLACE;

ALCOHOLISM; BIOLOGICAL MARKERS; CONSENSUS; HUMANS;

EID: 84887967837     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2013.838302     Document Type: Article

References (95)

1. Addison WR, Kurtz DT. 1986. Nucleotide sequences required for the regulation of a rat alpha 2u-globulin gene by gluco-corticoids. Mol Cell Biol 6: 2334-2346. (Pubitemid 17190582)
2. Agartz I, Momenan R, Rawlings R.R., Kerich MJ, Hommer DW. 1999. Hippocampal volume in patients with alcohol dependence. Arch Gen Psychiatry 56: 356-363. (Pubitemid 29165182)
3. Arias AJ, Sewell RA. CNS Drugs. 2012. Pharmacogenetically driven treatments for alcoholism: are we there yet? CNS Drugs 26: 461-476.
4. Atkinson RM, Ryan SC, Turner JA. 2001. Variation among again alcoholic patients in treatment. Am J Geriatr Psychiatry 9: 275-282. (Pubitemid 32642979)
5. Bühler M., Mann K. 2011. Alcohol and the human brain: a systematic review of different neuroimaging methods. Alcohol Clin Exp Res 35: 1771-1793.
6. Babor TF, Kranzler HR, Lauerman RJ. 1989. Early detection of harmful alcohol consumption: comparison of clinical, laboratory, and self-report screening procedures. Addict Behav 14: 139-157. (Pubitemid 19157711)
7. Barr CS, Schwandt M, Lindell S.G., Chen SA, Goldman D, et al. 2007. Association of a functional polymorphism in the mu-opioid receptor gene with alcohol response and consumption in male rhesus macaques. Arch Gen Psychiatry 64: 369-376. (Pubitemid 46376788)
8. Begleiter H, Porjesz B. 1999. What is inherited in the predisposition toward alcoholism? A proposed model. Alcohol Clin Exp Res 23: 1125-1135. (Pubitemid 29352798)
9. Benegal V, Antony G, Venkatasubramanian G., Jayakumar PN. 2007. Gray matter volume abnormalities and externalizing symptoms in subjects at high risk for alcohol dependence. Addict Biol 12: 122-132. (Pubitemid 46405996)
10. Cappadocia MC, Desrocher M, Pepler D., Schroeder JH. 2009. Contextualizing the neurobiology of conduct disorder in an emotion dysregulation framework. Clin Psychol Rev 29: 506-518.
11. Casey BJ, Jones RM. 2010. Neurobiology of the adolescent brain and behavior: implications for substance use disorders. J Am Acad Child Adolesc Psychiatry 49: 1189-1201.
12. Cheema ZF, West JR, Miranda RC. 2000. Ethanol induces Fas/Apo [apotosis]-1 mRNA and cell suicide in the developing cerebral cortex. Alcohol Clin Exp Res 24: 535-543. (Pubitemid 30244253)
13. Chen J, Conigrave KM, Macaskill P, Whitfield J.B., Irwig L. 2003. Combining carbohydrate-deficient transferrin and gamma-glutamyltransferase to increase diagnostic accuracy for problem drinking. Alcohol Alcohol 38: 574-582. (Pubitemid 37455855)
14. Conigrave KM, Davies P, Haber P., Whitfield JB. 2003. Traditional markers of excessive alcohol use. Addiction 98: 31-43. (Pubitemid 38030760)
15. Cornelius JR, Bukstein O, Salloum I., Clark D. 2003. Alcohol and psychiatric comorbidity. Recent Dev Alcohol 16: 361-374.
16. D'Souza D.C., Gil RB, Madonick S, Perry E.B., Forselius BK, et al. 2006. Enhanced sensitivity to the euphoric effects of alcohol in schizophrenia. Neuropsychopharmacology 31: 2767-2775. (Pubitemid 44764173)
17. Desrivieres S, Pronko SP, Lourdusamy A, Ducci F., Hoffman PL, et al. 2011. Sex-specific role for adenylyl cyclase type 7 in alcohol dependence. Biol Psychiatry 69: 1100-1108.
18. Dick DM, Aliev F, Bierut L., Goate A, Rice J, et al. 2006a. Linkage analyses of IQ in the collaborative study on the genetics of alcoholism (COGA) sample. Behav Genet 36: 77-86.
19. Dick DM, Jones K, Saccone N., Hinrichs A, Wang JC, et al. 2006b. Endophenotypes successfully lead to gene identification: results from the collaborative study on the genetics of alcoholism. Behav Genet 36: 112-126.
20. Dick DM, Aliev F, Saccone S., Hinrichs A, Wang JC, et al. 2007. A systematic SNP screen to fine-map alcohol dependence genes on chromosome 7 in the collaborative study on the genetics of alcoholism (COGA) sample. Behav Genetics 37: 748.
21. Dick DM, Edenberg HJ, Xuei X, Goate A., Kuperman S, et al. 2004. Association of GABRG3 with alcohol dependence. Alcohol Clin Exp Res 28: 4-9. (Pubitemid 38114017)
22. Dillie KS, Mundt M, French M.T., Fleming MF. 2005. Cost-benefit analysis of a new alcohol biomarker, carbohydrate deficient transferrin, in a chronic illness primary care sample. Alcohol Clin Exp Res 29: 2008-2014. (Pubitemid 41790839)
23. Dolman JM, Hawkes ND. 2005. Combining the audit questionnaire and biochemical markers to assess alcohol use and risk of alcohol withdrawal in medical inpatients. Alcohol Alcohol 40: 515-519. (Pubitemid 41600002)
24. Ducci F, Goldman D. 2008. Genetic approaches to addiction: genes and alcohol. Addiction. 103: 1414-1428.
25. Edenberg HJ, Dick DM, Xuei X, Tian H., Almasy L, et al. 2004. Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations. Am J Hum Genet 74: 705-714. (Pubitemid 38420099)
26. Edenberg HJ, Xuei X, Chen H.J., Tian H., Wetherill LF, et al. 2006. Association of alcohol dehydrogenase genes with alcohol dependence: a comprehensive analysis. Hum Mol Genet 15: 1539-1549.
27. Ehlers CL, Garcia AC, Wall T.L., Cloutier D., Phillips E. 1999. Electroencephalographic responses to alcohol challenge in Native American Mission Indians. Biol Psychiatry 15: 776-787. (Pubitemid 29159055)
28. Enoch MA. 2012. The influence of gene-environment interactions on the development of alcoholism and drug dependence. Curr Psychiatry Rep 14: 150-158.
29. Enoch MA, Schuckit MA, Johnson B.A., Goldman D. 2003. Genetics of alcoholism using intermediate phenotypes. Alcohol Clin Exp Res 27: 169-176. (Pubitemid 36236640)
30. Fein G, Shimotsu R, Chu R., Barakos J. 2009. Parietal gray matter volume loss is related to spatial processing deficits in long-term abstinent alcoholic men. Alcohol Clin Exp Res 33: 1806-1814.
31. Feinman JA, Dunner DL. 1996. The effect of alcohol and substance abuse on the course of bipolar affective disorder. J Affect Disord 37: 43-49. (Pubitemid 26072815)
32. Finn PR. 2002. Motivation, working memory, and decision making: a cognitive-motivational theory of personality vulnerability to alcoholism. Behav Cogn Neurosci Rev 1: 183-205.
33. Fleming M, Bhamb B, Schurr M., Mundt M, Williams A. 2009. Alcohol biomarkers in patients admitted for trauma. Alcohol Clin Exp Res 33: 1777-1781.
34. Fleming M, Brown R, Brown D. 2004. The efficacy of a brief alcohol intervention combined with %CDT feedback in patients being treated for type 2 diabetes and/or hypertension. J Stud Alcohol 65: 631-637. (Pubitemid 39383194)
35. Flint J, Munafo MR. 2007. The endophenotype concept in psychiatric genetics. Psychol Med 37: 163-180. (Pubitemid 46158160)
36. González-Illán F, Ojeda-Torres G, Díaz- Vázquez LM, Rosario O. 2011. Detection of fatty acid ethyl esters in skin surface lipids as biomarkers of ethanol consumption in alcoholics, social drinkers, light drinkers, and teetotalers using a methodology based on microwave-assisted extraction followed by solid-phase microextraction and gas chromatography-mass spectrometry. J Anal Toxicol 35: 232-237.
37. Hayes GA, Templer DI, Jansen M.A., Graham CR. 1989. Alcoholism: abstinence, improvement, and no improvement in general population. Adv Alcohol Subst Abuse 8: 87-96. (Pubitemid 19162600)
38. Heath AC, Madden PA, Bucholz K.K., Dinwiddie SH, Slutske WS, et al. 1999. Genetic differences in alcohol sensitivity and the inheritance of alcoholism risk. Psychol Med 29: 1069-1081. (Pubitemid 29469297)
39. Helander A, Péter O, Zheng Y. 2012. Monitoring of the alcohol biomarkers PEth, CDT and EtG/EtS in an outpatient treatment setting. Alcohol Alcohol [Epub ahead of print].
40. Hermansson U, Helander A, Huss A., Brandt L, Ronnberg S. 2000. The Alcohol Use Disorders Identification Test (AUDIT) and carbohydrate-deficient transferrin (CDT) in a routine workplace health examination. Alcohol Clin Exp Res 24: 180-187. (Pubitemid 30117420)
41. Hietala J, Koivisto H, Anttila P., Niemela O. 2006. Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers. Alcohol Alcohol 41: 528-533. (Pubitemid 44404470)
42. Hines LM, Ray L, Hutchison K., Tabakoff B. 2005. Alcoholism: the dissection for endophenotypes. Dialogues Clin Neurosci 7: 153-163. (Pubitemid 40961535)
43. Hoefer P, Syeda B, Bergler K.J., Friedrich F., Lesch OM, et al. 2011. Amino-terminal pro-B-type brain natriuretic Peptide: screening for cardiovascular disease in the setting of alcoholism. Alcohol Alcohol 46: 247-252.
44. Isaksson A, Walther L, Hansson T., Andersson A, Alling C. 2011. Phosphatidylethanol in blood (B-PEth): a marker for alcohol use and abuse. Drug Test Anal 3: 195-200.
45. Jellinek EM. 1960. Alcoholism, a genus and some of its species. Can Med Assoc J 83: 1341-1345.
46. Kendler KS, Prescott CA, Myers J, Neale MC. 2003. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry 60: 923-937.
47. Kendler KS, Chen X, Dick D., Maes H, Gillespie N, Neale M.C., Riley B. 2012. Recent advances in the genetic epidemiology and molecular genetics of substance use disorders. Nat Neurosci 15: 181-189.
48. Koob GF. 2012. Animal models of psychiatric disorders. Handb Clin Neurol 106: 137-166.
49. Kumari M, Ticku MK. 2000. Regulation of NMDA receptors by ethanol. Prog Drug Res 54: 152-189.
50. Lamy S, Thibaut F. 2011. Biological markers of exposure of foetus to alcohol during pregnancy. In Hoffman JD, editor. Pregnancy and Alcohol Consumption. Public Health in the 21st century. Ch 15. New York, NY: Nova Science Publishers, Inc; 2011. p 347-358.
51. Lapham SC, C'de Baca J, McMillan G, Hunt WC. 2004. Accuracy of alcohol diagnosis among DWI offenders referred for screening. Drug Alcohol Depend 76: 135-141. (Pubitemid 39370809)
52. Le Fauve C.E., Litten RZ, Randall C.L., Moak DH, Salloum IM, Green AI. 2004. Pharmacological treatment of alcohol abuse/dependence with psychiatric comorbidity. Alcohol Clin Exp Res 28: 302-312. (Pubitemid 38233608)
53. Lenz B, Jacob C, Frieling H., Jacobi A, Hillemacher T, et al. 2009. Polymorphism of the long polyglutamine tract in the human androgen receptor influences craving of men in alcohol withdrawal. Psychoneuroendocrinology 34: 968-971.
54. Makris N, Oscar BM, Jaffin S.K., Hodge SM, Kennedy DN, et al. 2008. Decreased volume of the brain reward system in alcoholism. Biol Psychiatry 64: 192-202.
55. Mann K, Kiefer F, Smolka M., Gann H, Wellek S, Heinz A. 2009. Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study. Alcohol Clin Exp Res 33: 674-683.
56. Manning TJ, Bundred EP, Newton J.D., Flanagan FB. 2003. The second to fourth digit ratio and variation in the androgen receptor gene. Evol Hum Behav 24: 399-405.
57. Menninger JA, Baron AE, Conigrave K.M., Whitfield JB, Saunders JB, et al. 2000. Platelet adenylyl cyclase activity as a trait marker of alcohol dependence. WHO/ISBRA Collaborative Study Investigators. International Society for Biomedical Research on Alcoholism. Alcohol Clin Exp Res 24: 810-821. (Pubitemid 30421731)
58. Miller PM, Spies C, Neumann T., Javors MA, Hoyumpa AM, et al. 2006. Alcohol biomarker screening in medical and surgical settings. Alcohol Clin Exp Res 30: 185-193. (Pubitemid 43341368)
59. Nurnberger JIJ, Bierut LJ. 2007. Seeking the connections: alcoholism and our genes. http://www.sciam.com/article.cfm?id=seeking-the-connections- alcoholism-and-our-genes
60. Nyblom H, Berggren U, Balldin J., Olsson R. 2004. High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. Alcohol Alcohol 39: 336-339. (Pubitemid 38968090)
61. Ohkawa H, Sohma H, Sakai R., Kuroki Y, Hashimoto E, et al. 2002. Ethanol-induced augmentation of annexin IV in cultured cells and the enhancement of cytotoxicity by overexpression of annexin IV by ethanol. Biochim Biophys Acta 1588: 217-225. (Pubitemid 35223465)
62. Pescosolido BA, Perry BL, Scott Long J, Martin JK. 2008. Under the influence of genetics: how transdisciplinarity leads us to rethink social pathways to illness. Am J Sociol 114(Suppl): S171-201.
63. Peterson K. 2004-2005. Biomarkers for alcohol use and abuse - a summary. Alcohol Res Health 28: 30-37. (Pubitemid 41595218)
64. Pfefferbaum A, Sullivan EV, Mathalon D.H., Shear PK, Rosenbloom MJ, Lim KO. 1995. Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics. Alcohol Clin Exp Res 19: 1177-1191.
65. Pollock VE. 1992. Meta-analysis of subjective sensitivity to alcohol in sons of alcoholics. Am J Psychiatry 149: 1534-1538.
66. Porjesz B, Begleiter H, Reich T., Van Eerdewegh P, Edenberg HJ, et al. 1998a. Amplitude of visual P3 event-related potential as a phenotypic marker for a predisposition to alcoholism: preliminary results from the COGA Project. Collaborative Study on the Genetics of Alcoholism. Alcohol Clin Exp Res 22: 1317-1323. (Pubitemid 28443156)
67. Porjesz B, Begleiter H, Reich T., Van EP, Edenberg HJ, et al. 1998b. Amplitude of visual P3 event-related potential as a phenotypic marker for a predisposition to alcoholism: preliminary results from the COGA Project. Collaborative Study on the Genetics of Alcoholism. Alcohol Clin Exp Res 22: 1317-1323. (Pubitemid 28443156)
68. Ratsma JE, Van Der Stelt O, Gunning WB. 2002. Neurochemical markers of alcoholism vulnerability in humans. Alcohol Alcohol 37: 522-533. (Pubitemid 35385884)
69. Ray LA, Hutchison KE. 2009. Associations among GABRG1, level of response to alcohol, and drinking behaviors. Alcohol Clin Exp Res 33: 1382-1390.
70. Regier DA, Farmer ME, Rae D.S., Locke BZ, Keith SJ, et al. 1990. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. J Am Med Assoc 264: 2511-2518.
71. Rodriguez Holguin S., Porjesz B, Chorlian D.B., Polich J., Begleiter H. 1999. Visual P3a in male alcoholics and controls. Alcohol Clin Exp Res 23: 582-591. (Pubitemid 29203212)
72. Saito M, Saito M, Berg M.J., Guidotti A., Marks N. 1999. Ganagliosides attenuate ethanol-induced apoptosis in rat cerebellar granule neurons. Neurochem Res 24: 1107-1115. (Pubitemid 29413599)
73. Sameti M, Smith S, Patenaude B., Fein G. 2011. Subcortical volumes in long-term abstinent alcoholics: associations with psychiatric comorbidity. Alcohol Clin Exp Res 35: 1067-1080.
74. Schneider F, Habel U, Wagner M., Franke P, Salloum JB, et al. 2001. Subcortical correlates of craving in recently abstinent alcoholic patients. Am J Psychiatry 158: 1075-1083. (Pubitemid 32623111)
75. Schuckit MA. 1986. Biological markers in alcoholism. Prog Neuropsychopharmacol Biol Psychiatry 10: 191-199. (Pubitemid 16061394)
76. Schuckit MA. 1999. New findings in the genetics of alcoholism. J Am Med Assoc 26: 1875-1876. (Pubitemid 29242792)
77. Schuckit MA, Smith TL, Kalmijn J, Tsuang J., Hesselbrock V, Bucholz K. 2000. Response to alcohol in daughters of alcoholics: a pilot study and a comparison with sons of alcoholics. Alcohol Alcohol 35: 242-248. (Pubitemid 30433694)
78. Schuckit MA, Tsuang WJ, Anthenelli M.R., Tipp EJ, Nurnberger IJ. 1996. Alcohol challenges in young men from alcoholic pedigrees and control families: a report from the COGA project. J Stud Alcohol 57: 368-377.
79. Schweinsburg AD, Paulus MP, Barlett V.C., Killeen LA, Caldwell LC, et al. 2004. An FMRI study of response inhibition in youths with a family history of alcoholism. Ann NY Acad Sci 1021: 391-394. (Pubitemid 38879651)
80. Sogawa K, Kodera Y, Satoh M., Kawashima Y, Umemura H, et al. 2011. Increased serum levels of pigment epithelium-derived factor by excessive alcohol consumption-detection and identification by a three-step serum proteome analysis. Alcohol Clin Exp Res 35: 211-217.
81. Sohma H, Hashimoto E, Shirasaka T., Tsunematsu R, Ozawa H, et al. 1999. Quantitative reduction of type I adenylyl cyclase in human alcoholics. Biochim Biophys Acta 1454: 11-18. (Pubitemid 29238093)
82. Sorbi D, Boynton J, Lindor KD. 1999. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol 94: 1018-1022. (Pubitemid 29173621)
83. Spies CD, Kissner M, Neumann T., Blum S, Voigt C, et al. 1998. Elevated carbohydrate-deficient transferrin predicts prolonged intensive care unit stay in traumatized men. Alcohol Alcohol 33: 661-669. (Pubitemid 28548396)
84. Sullivan EV, Deshmukh A, De R.E., Rosenbloom MJ, Pfefferbaum A. 2005. Striatal and forebrain nuclei volumes: contribution to motor function and working memory deficits in alcoholism. Biol Psychiatry 57: 768-776. (Pubitemid 40487921)
85. Sullivan EV, Marsh L, Mathalon D.H., Lim KO, Pfefferbaum A. 1995. Anterior hippocampal volume deficits in nonamnesic, aging chronic alcoholics. Alcohol Clin Exp Res 19: 110-122.
86. Szuromi B, Czobor P, Komlosi S., Bitter I. 2011. P300 deficits in adults with attention deficit hyperactivity disorder: a metaanalysis. Psychol Med 41: 1529-1538.
87. Viken RJ, Rose RJ, Morzorati S.L., Christian JC, Li TK. 2003. Subjective intoxication in response to alcohol challenge: heritability and covariation with personality, breath alcohol level, and drinking history. Alcohol Clin Exp Res 27: 795-803. (Pubitemid 36583362)
88. Wall TL, Johnson ML, Horn S.M., Carr LG, Smith TL, Schuckit MA. 1999. Evaluation of the self-rating of the effects of alcohol form in Asian Americans with aldehyde dehydrogenase polymorphisms. J Stud Alcohol 60: 784-789. (Pubitemid 29526543)
89. Webb A, Lind PA, Kalmijn J, Feiler H.S., Smith TL, et al. 2011. The investigation into CYP2E1 in relation to the level of response to alcohol through a combination of linkage and association analysis. Alcohol Clin Exp Res 35: 10-18.
90. Williams JHG, Greenhalgh KD, Manning JT. 2003. Second to fourth finger ratio and possible precursors of developmental psychopathology in preschool children. Early Hum Dev 72: 57-65. (Pubitemid 36434273)
91. Wills TA, Vaccaro D, McNamara G. 1994. Novelty seeking, risk taking, and related constructs as predictors of adolescent substance use: an application of Cloninger's theory. J Subst Abuse 6: 1-20.
92. Winokur G, Coryell W, Endicott J., Keller M, Akiskal H, Solomon D. 1996. Familial alcoholism in manic-depressive (bipolar) disease. Am J Med Genet 9: 197-201.
93. Wrase J, Makris N, Braus D.F., Mann K., Smolka MN, et al. 2008. Amygdala volume associated with alcohol abuse relapse and craving. Am J Psychiatry 165: 1179-1184.
94. Wurst FM, Kelso E, Weinmann W, Pragst F, Yegles M, Sundstroem PI. 2008. Measurement of direct ethanol metabolites suggests higher rate of alcohol use among pregnant women than found with the AUDIT - a pilot study in a population-based sample of Swedish women. Am J Obstet Gynecol 198: 407.
95. Wurst FM, Skipper GE, Weinmann W. 2003. Ethyl glucuronide - the direct ethanol metabolite on the threshold from science to routine use. Addiction 98(Suppl 2): 51-61. (Pubitemid 38030762)